close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sensei Biotherapeutics, Inc.

News headline image
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
News headline image
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
From Sensei Biotherapeutics, Inc.
Via Business Wire
Tickers SNSE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today